• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT, INC. SPECTRA OPTIA APHERESIS SYSTEM; SEPARATOR, AUTOMATED, BLOOD CELL AND PLASMA THERAPEUTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT, INC. SPECTRA OPTIA APHERESIS SYSTEM; SEPARATOR, AUTOMATED, BLOOD CELL AND PLASMA THERAPEUTIC Back to Search Results
Model Number SPECTRA PTIA
Device Problems Defective Component (2292); Device Displays Incorrect Message (2591)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/10/2019
Event Type  Injury  
Event Description
An autologous cellular therapy (ctp) collection was performed on a (b)(6) y/o male, diagnosed with multiple myeloma.The ctp collection was performed per protocol without any issues throughout the procedure, except for a few occlusion alarms towards the last hour of the procedure which were central venous catheter related.The pt peripheral cd 34 count of 90 and a total of 16.182 liters of whole blood was processed via a triple lumen trifusion central venous catheter.Acda-a ratio used throughout the procedure was 12:1.At the end of the procedure the ctp labeling was verified for accuracy and visual inspection of the ctp was performed and authenticated by two rns.No visual abnormalities of the ctp were noted prior to distribution to the processing facility.The processing facility personnel who accepted the ctp also confirmed the visual inspection of the ctp showed no abnormalities at the time of distribution.At approx 1400, as stated by the processing facility personnel, the md was notified and he visually assessed the ctp.After close inspection of the ctp, the ctp was deemed unusable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA APHERESIS SYSTEM
Type of Device
SEPARATOR, AUTOMATED, BLOOD CELL AND PLASMA THERAPEUTIC
Manufacturer (Section D)
TERUMO BCT, INC.
10811 w. collins ave
lakewood CO 80215
MDR Report Key9426837
MDR Text Key169897027
Report NumberMW5091508
Device Sequence Number1
Product Code LKN
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 10/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSPECTRA PTIA
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/05/2019
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight63
-
-